(Q37986572)

26 August 2017

Mild cognitive impairment in Parkinson disease: heterogenous mechanisms (English)

1 reference

mild cognitive impairment

26 August 2017

1 reference

1 reference

inferred from title

cognitive dysfunction

1 reference

Kurt A Jellinger

1

1 reference

26 August 2017

18 February 2012

1 reference

Journal of Neural Transmission

26 August 2017

1 reference

26 August 2017

120

1 reference

26 August 2017

1

1 reference

26 August 2017

157-167

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-012-0771-5

26 August 2017

0 references

cites work

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cognitive impairment in nondemented Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Defining mild cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Characterizing mild cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Differential impact of ApoE ε4 on cortical activation during famous face recognition in cognitively intact individuals and patients with amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment, amnestic type: an epidemiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Outcomes of mild cognitive impairment by definition: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cholinergic system function and cognition in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Functional impairment in the diagnosis of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the National Alzheimer's Coordinating Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Predicting MCI outcome with clinically available MRI and CSF biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment is associated with mild parkinsonian signs in a door-to-door study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Differential hypometabolism patterns according to mild cognitive impairment subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

The neuropathologic substrate of Parkinson disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Clinical features of mild cognitive impairment differ in the research and tertiary clinic settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Preclinical AD Workgroup staging: pathological correlates and potential challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

The morbid anatomy of dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Comparing predictors of conversion and decline in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Incidence of mild cognitive impairment: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuropathologic alterations in mild cognitive impairment: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuropathologic substrate of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Early Alzheimer's disease. Diagnostic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment represents early-stage Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cognitive profile of patients with newly diagnosed Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Late-life depression, mild cognitive impairment, and dementia: possible continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

The neuropathologic basis of different clinical subgroups of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment as a clinical entity and treatment target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuropathologic features of amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Incidence of dementia and cognitive impairment, not dementia in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Judgment in older adults: development and psychometric evaluation of the Test of Practical Judgment (TOP-J).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment--proof of concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuropathology of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

The neuropathology of probable Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Biomarkers for cognitive impairment in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuroimaging and cognition in Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Progression from mild to pronounced MCI is not associated with cerebrospinal fluid biomarker deviations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment: disparity of incidence and prevalence estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neurodegeneration across stages of cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Amyloid imaging in mild cognitive impairment subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Neuropsychological profiles in MCI and in depression: Differential cognitive dysfunction patterns or similar final common pathway disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0771-5

21 January 2018

1 reference

12 December 2020

Mild cognitive impairment: prodromal Alzheimer's disease or something else?

1 reference

12 December 2020

Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease

1 reference

12 December 2020

Neuropathology in Parkinson's disease with mild cognitive impairment

1 reference

12 December 2020

[Association of Mild Cognitive Impairment (MCI) and depression]

1 reference

12 December 2020

Using diffusion tensor imaging and mixed-effects models to investigate primary and secondary white matter degeneration in Alzheimer's disease and mild cognitive impairment.

1 reference

12 December 2020

A précis of recent advances in the neuropsychology of mild cognitive impairment(s) in Parkinson's disease and a proposal of preliminary research criteria

1 reference

12 December 2020

Cognitive impairment and dementia in Parkinson's disease

1 reference

12 December 2020

Is there a neuropathology difference between mild cognitive impairment and dementia?

1 reference

12 December 2020

Neuropathological profile of mild cognitive impairment from a population perspective.

1 reference

12 December 2020

A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease

1 reference

12 December 2020

Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson's disease

1 reference

12 December 2020

Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI

1 reference

12 December 2020

Mild cognitive impairment is not a clinical entity and should not be treated

1 reference

12 December 2020

Mild cognitive impairment: pathology and mechanisms.

1 reference

12 December 2020

10.1007/S00702-012-0771-5

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22350538